Firefly Bio

About Firefly Bio

Firefly Bio is a biotechnology company focused on reimagining Antibody Drug Conjugates (ADCs) through their proprietary platform for Degrader Antibody Conjugates (DACs). Their mission is to deliver highly specific degraders to target tissues and explore complex challenges with a diverse team of innovators.

Products & Services

Degrader Antibody Conjugates (DACs):A specialized platform combining the strengths of ADCs with selective protein degraders for highly specific delivery to target tissues.

Specialties

Antibody Drug Conjugates (ADCs) Degrader Antibody Conjugates (DACs) Selective Protein Degraders

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 94000000 MR: - FA: $94 million FAN: 94000000	D: 2024-02-15 FD: 2024-02-15	4 investors

Series A Latest

2024-02-15

$94.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Scott Hirsch

CEO

V

Vinayak Vittal

Head of Corporate Development

M

Megan Williams

VP, Strategy and Portfolio Management

S

Sean Smith

VP, Head of Chemistry

P

Pankaj Bhargava

Director

P

Peter Colobuono

Director

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

Firefly Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised